← Human Trials & Peer-Reviewed Studies
Novel Adjuvant Therapy with Zinc Supplementation in Neonatal Respiratory Distress Syndrome.
Plain-language guide to PMID 34325645 (2021): randomized controlled trial of Vitamin D, K2, Magnesium and Zinc.
Key Facts
- PMID
- 34325645
- Journal
- Endocrine, metabolic & immune disorders drug targets
- Year
- 2021
- Study type
- Randomized Controlled Trial
- Authors
- Elfarargy MS et al. (4 authors)
- DOI
- 10.2174/1871530321666210729113515
What This Study Did, in Plain Language
What Was Tested
Researchers studied Vitamin D, K2, Magnesium and Zinc in this randomized controlled trial publication.
The aim of this study was to show the role of zinc as an adjuvant anti-inflammatory therapy in neonatal RDS.
To study the effect of zinc supplementation in cases of neonatal RDS.
Why It Was Studied
Neonatal respiratory distress syndrome (RDS) is a common dangerous chest problem that is caused by a lack of surfactant.
Zn supplementation for RDS neonates.
Who Took Part
The included neonates were classified into two groups: group 1, which received Zinc (Zn) supplementation, and group 2, which received a placebo.
How the Study Was Run
In design terms this was a randomized and placebo-controlled study.
Because people in this Vitamin D, K2, Magnesium and Zinc study were split into groups at random, differences between the groups are less likely to reflect who happened to join each one.
A placebo (an inactive look-alike) gave the Vitamin D, K2, Magnesium and Zinc group a baseline to be compared against.
A prospective randomized controlled trial (RCT) study was done on 90 neonates suffering from respiratory distress (RD) who had been diagnosed as RDS.
Down score, grades of RDS Malondialdehyde (MDA), Superoxide Dismutase (SOD) andInterleukin-8 (IL-8) were estimated on the 1st and 5th day in the presence of incubators.
What Was Measured
Topics PubMed links to this paper include Dietary Supplements, Infant, Premature, Pulmonary Surfactants, Respiratory Distress Syndrome, Newborn and Zinc.
Author keywords: Neonate, adjuvant, supplementation, syndrome and therapy.
What This Means in Plain Language
The paper is a randomized and placebo-controlled study of Vitamin D, K2, Magnesium and Zinc.
Its findings take up roughly 3 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.
The publication is from 2021 (Endocrine, metabolic & immune disorders drug targets), a journal based in United Arab Emirates.
More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.
Our Notes on the Compound
Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.